MENU

MPLT MapLight Therapeutics Inc. Forecast, Technical & Fundamental Analysis

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders... Show more

MPLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
MPLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MPLT is expected to report earnings to fall 22.73% to -101 cents per share on December 03

MapLight Therapeutics Inc. MPLT Stock Earnings Reports
Q3'26
Est.
$-1.02
Q2'26
Missed
by $0.33
Q1'26
Missed
by $0.42
The last earnings report on August 13 showed earnings per share of -132 cents, missing the estimate of -99 cents. With 207.52K shares outstanding, the current market capitalization sits at 580.77M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
800 Chesapeake Drive
Phone
+1 617 984-6300
Employees
133
Web
https://www.maplightrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAPR9.470.90
+10.50%
Capricor Therapeutics
NRT8.500.33
+4.04%
North European Oil Royalty Trust
TTAM13.63-0.13
-0.94%
Titan America SA
ARCC19.10-0.26
-1.34%
Ares Capital Corp
WHLR3.25-0.09
-2.69%
Wheeler Real Estate Investment Trust Inc
MapLight Therapeutics (MPLT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com